Simplex Trading

Simplex Trading Portfolio holdings

AUM $3.72B
1-Year Return 0.6%
 

Simplex Trading, founded in 2004 and headquartered in Chicago, Illinois, is a technology-driven proprietary trading firm specializing in market-making and liquidity provision, primarily in U.S. equity options and futures options. Leveraging advanced proprietary software and data-driven analysis, the firm optimizes trading strategies and develops innovative solutions to capitalize on financial market opportunities, maintaining a competitive edge through automation and a collaborative team of technologists and traders. With a workforce exceeding 300 and led by CEO Erik Swanson since 2014, Simplex operates with a low-ego, high-intelligence culture, focusing on minimal bureaucracy and rapid execution, while also making strategic venture capital investments in fintech startups. Recognized as a top workplace in Chicago by Built In’s 2025 awards, Simplex continues to evolve, blending cutting-edge technology with a commitment to market efficiency and growth.

This Quarter Return
+2.71%
1 Year Return
+0.6%
3 Year Return
+1.23%
5 Year Return
+2.7%
10 Year Return
+32.99%
AUM
$791M
AUM Growth
+$153M
Cap. Flow
+$155M
Cap. Flow %
19.59%
Top 10 Hldgs %
24.92%
Holding
3,551
New
748
Increased
516
Reduced
411
Closed
720

Sector Composition

1 Communication Services 12.51%
2 Healthcare 12.38%
3 Technology 12.22%
4 Consumer Discretionary 8.59%
5 Financials 8.53%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
BIB icon
1001
ProShares Ultra NASDAQ Biotechnology
BIB
$57.5M
$36K ﹤0.01%
952
-3,681
-79% -$139K
DMLP icon
1002
Dorchester Minerals
DMLP
$1.21B
$36K ﹤0.01%
2,550
+1,915
+302% +$27K
KOS icon
1003
Kosmos Energy
KOS
$827M
$36K ﹤0.01%
+6,786
New +$36K
SCHD icon
1004
Schwab US Dividend Equity ETF
SCHD
$72.2B
$36K ﹤0.01%
+2,619
New +$36K
CDK
1005
DELISTED
CDK Global, Inc.
CDK
$36K ﹤0.01%
654
-671
-51% -$36.9K
MACK
1006
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$36K ﹤0.01%
869
-103
-11% -$4.27K
DBVT
1007
DBV Technologies
DBVT
$272M
$35K ﹤0.01%
+109
New +$35K
FARO
1008
DELISTED
Faro Technologies
FARO
$35K ﹤0.01%
+1,040
New +$35K
NOAH
1009
Noah Holdings
NOAH
$793M
$35K ﹤0.01%
+1,475
New +$35K
NVCR icon
1010
NovoCure
NVCR
$1.42B
$35K ﹤0.01%
+3,023
New +$35K
SAAS
1011
DELISTED
inContact, Inc.
SAAS
$35K ﹤0.01%
2,546
+1,732
+213% +$23.8K
CSTM icon
1012
Constellium
CSTM
$2.09B
$34K ﹤0.01%
7,325
+5,648
+337% +$26.2K
ORMP icon
1013
Oramed Pharmaceuticals
ORMP
$99.6M
$34K ﹤0.01%
4,173
+3,421
+455% +$27.9K
STE icon
1014
Steris
STE
$24.9B
$34K ﹤0.01%
+504
New +$34K
VRE
1015
Veris Residential
VRE
$1.51B
$34K ﹤0.01%
1,266
+813
+179% +$21.8K
IMGN
1016
DELISTED
Immunogen Inc
IMGN
$34K ﹤0.01%
11,242
-1,528
-12% -$4.62K
TACO
1017
DELISTED
Del Taco Restaurants, Inc. Common Stock
TACO
$34K ﹤0.01%
+3,831
New +$34K
AHT
1018
Ashford Hospitality Trust
AHT
$37.9M
$33K ﹤0.01%
+6
New +$33K
FRPT icon
1019
Freshpet
FRPT
$2.6B
$33K ﹤0.01%
3,540
+2,478
+233% +$23.1K
UHS icon
1020
Universal Health Services
UHS
$12.1B
$33K ﹤0.01%
+251
New +$33K
VEA icon
1021
Vanguard FTSE Developed Markets ETF
VEA
$175B
$33K ﹤0.01%
+960
New +$33K
ARNA
1022
DELISTED
Arena Pharmaceuticals Inc
ARNA
$33K ﹤0.01%
1,937
+148
+8% +$2.52K
TVIA
1023
DELISTED
TerraVia Holdings, Inc. Common Stock
TVIA
$33K ﹤0.01%
+12,746
New +$33K
AORT icon
1024
Artivion
AORT
$2B
$32K ﹤0.01%
2,783
+1,408
+102% +$16.2K
ATRA icon
1025
Atara Biotherapeutics
ATRA
$85.4M
$32K ﹤0.01%
57
+31
+119% +$17.4K